Likewise, adoptively transferred anti-tumor CD8+ T cells harboring a deletion of TNFAIP3 enhanced IFN-γ and TNF-α production and reduced PD-1 expression, which exhibited superior anti-tumor activity in vivo (189, 190). The gene discussed is CD8A; the disease is neoplasm.